![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 2, 657-665, January 8, 1999
-Glucuronidase Enzymatic Activity
From the Departments of a Genetics, d Molecular
Pharmacology, and e Microbiology and Immunology, Stanford
University Medical School, Stanford, California 94305, the
c Department of Pathobiology, School of Veterinary Medicine,
University of Pennsylvania, Philadelphia, Pennsylvania 19104, g Molecular Probes, Inc., Eugene, Oregon 97402, and the
h Molecular Medicine Division, Fred Hutchinson Cancer Research
Center, Seattle, Washington 98019
Mutations in the acid
-glucuronidase gene lead
to systemic accumulation of undegraded glycosaminoglycans in lysosomes
and ultimately to clinical manifestations of mucopolysaccharidosis VII
(Sly disease). Gene transfer by retrovirus vectors into murine mucopolysaccharidosis VII hematopoietic stem cells or fibroblasts ameliorates glycosaminoglycan accumulation in some affected tissues. The efficacy of gene therapy for mucopolysaccharidosis VII depends on
the levels of
-glucuronidase secreted by gene-corrected cells; therefore, enrichment of transduced cells expressing high levels of
enzyme prior to transplantation is desirable. We describe the development of a fluorescence-activated cell sorter-based assay for the
quantitative analysis of
-glucuronidase activity in viable cells.
Murine mucopolysaccharidosis VII cells transduced with a
-glucuronidase retroviral vector can be isolated by cell sorting on
the basis of
-glucuronidase activity and cultured for further use.
In vitro analysis revealed that sorted cells have elevated levels of
-glucuronidase activity and secrete higher levels of cross-correcting enzyme than the population from which they were sorted. Transduced fibroblasts stably expressing
-glucuronidase after subcutaneous passage in the mucopolysaccharidosis VII mouse can
be isolated by cell sorting and expanded ex vivo. A
relatively high percentage of these cells maintain stable expression
after secondary transplantation, yielding significantly higher levels of enzymatic activity than that generated in the primary transplant.
This article has been cited by other articles:
![]() |
H. Lin, T.-Y. Li, M.-H. Xie, and Y. Zhang Characterization of the Variants, Flanking Genes, and Promoter Activity of the Leifsonia xyli subsp. cynodontis Insertion Sequence IS1237 J. Bacteriol., April 15, 2007; 189(8): 3217 - 3227. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Witkowski, M. Soroczynska-Cybula, E. Bryl, Z. Smolenska, and A. Jozwik Klotho--a Common Link in Physiological and Rheumatoid Arthritis-Related Aging of Human CD4+ Lymphocytes J. Immunol., January 15, 2007; 178(2): 771 - 777. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Hofling, C. Vogler, M. H. Creer, and M. S. Sands Engraftment of human CD34+ cells leads to widespread distribution of donor-derived cells and correction of tissue pathology in a novel murine xenotransplantation model of lysosomal storage disease Blood, March 1, 2003; 101(5): 2054 - 2063. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |